Factors associated with death from COVID-19 in traditional peoples and communities in Brazil
- PMID: 40638670
- PMCID: PMC12244660
- DOI: 10.1371/journal.pone.0327140
Factors associated with death from COVID-19 in traditional peoples and communities in Brazil
Abstract
Introduction: COVID-19 has disproportionately impacted vulnerable populations, including traditional communities in Brazil, who face socioeconomic and health disparities, increasing the risk of severe outcomes. This study aims to identify factors associated with mortality among hospitalized COVID-19 patients from traditional communities in Brazil.
Methods: This cross-sectional study analyzed data from the System of Epidemiological Surveillance of Influenza (SIVEP-Gripe) on hospitalizations for COVID-19 between 2021 and 2023. Individuals from traditional communities were included. The variables analyzed included demographic characteristics, clinical symptoms, comorbidities, and the need for hospital support. Logistic regressions were performed to assess associations with mortality, considering p < 0.05 significant.
Results: Of the 7,101 cases analyzed, males showed a higher risk of death (OR = 1.39; 95% CI: 1.18-1.63). Among ethnic groups, blacks presented with an OR = 2.92 (95% CI: 1.68-5.08) and indigenous, OR = 2.25 (95% CI: 1.73-2.94). Older age increased the risk, with OR = 6.57 (95% CI: 2.16-28.5) for ages 60-79 and OR = 12.8 (95% CI: 4.18-55.8) for ≥80 years. Dyspnea (OR = 2.16; 95% CI: 1.77-2.65) and low saturation (OR = 2.13; 95% CI: 1.78-2.55) were associated with death, while loss of taste was protective (OR = 0.62; 95% CI: 0.51-0.75). Immunosuppression (OR = 2.14; 95% CI: 1.23-3.79) and chronic renal disease (OR = 1.64; 95% CI: 1.10-2.46) increased the risk. Patients on invasive ventilation had the highest risk of death (OR = 19.4; 95% CI: 15.2-25.0), followed by non-invasive ventilation (OR = 2.65; 95% CI: 2.18-3.23) and ICU (OR = 2.15; 95% CI: 1.85-2.49).
Conclusion: Risk factors for mortality among hospitalized patients from traditional communities include male sex, older age, race/color, severe respiratory symptoms, comorbidities, and the need for invasive ventilation. These findings reinforce the importance of targeted health strategies to reduce the risk of mortality in these vulnerable populations.
Copyright: © 2025 Silva et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures

Similar articles
-
Huntington's Disease in Hospitalized Patients Infected with SARS-CoV-2 in Brazil: Three-Year Update.Neurodegener Dis. 2025;25(2):88-105. doi: 10.1159/000538170. Epub 2025 Feb 20. Neurodegener Dis. 2025. PMID: 39978329
-
Risk of Incidence and Lethality by Etiology of Severe Acute Respiratory Syndrome in Hospitalized Children Under 1 Year of Age in Brazil in 2024: A Cross-Sectional Study.Trop Med Infect Dis. 2025 Jun 14;10(6):168. doi: 10.3390/tropicalmed10060168. Trop Med Infect Dis. 2025. PMID: 40559735 Free PMC article.
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
-
SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.Cochrane Database Syst Rev. 2021 Sep 2;9(9):CD013825. doi: 10.1002/14651858.CD013825.pub2. Cochrane Database Syst Rev. 2021. PMID: 34473343 Free PMC article.
-
Surveillance for Violent Deaths - National Violent Death Reporting System, 50 States, the District of Columbia, and Puerto Rico, 2022.MMWR Surveill Summ. 2025 Jun 12;74(5):1-42. doi: 10.15585/mmwr.ss7405a1. MMWR Surveill Summ. 2025. PMID: 40493548 Free PMC article.
References
-
- World Health Organization. Coronavirus disease 2019 (COVID-19) situation report-72 highlights. 2020. www.who.int/epi-win
-
- Brasil M d a S. Guia de vigilância epidemiológica emergência de saúde pública de importância nacional pelo coronavírus 2019. 2021. www.saude.gov.br
MeSH terms
LinkOut - more resources
Full Text Sources
Medical